HER-2 and topo-isomerase IIalpha as predictive markers in a population of node-positive breast cancer patients randomly treated with adjuvant CMF or epirubicin plus cyclophosphamide

Leo A Di; PH Gobert; MT Closon-dejardin; S Dolci; G Rouas; M Paesmans; JP Lobelle; J Isola; MJ Piccart; D Larsimont; D Gancberg; T Järvinen; M Beauduin; A Vindevoghel; J Michel; CH Focan; F Ries

HER-2 and topo-isomerase IIalpha as predictive markers in a population of node-positive breast cancer patients randomly treated with adjuvant CMF or epirubicin plus cyclophosphamide

Leo A Di
, PH Gobert
, MT Closon-dejardin
, S Dolci
, G Rouas
, M Paesmans
, JP Lobelle
, J Isola
, MJ Piccart
, D Larsimont
, D Gancberg
, T Järvinen
, M Beauduin
, A Vindevoghel
, J Michel
, CH Focan
, F Ries

Department of Clinical Chemistry

Research output: Contribution to journal › Article › Scientific › peer-review

108 Citations (Scopus)

Original language	English
Pages (from-to)	1081-1089
Journal	Annals of Oncology
Volume	12
Issue number	8
Publication status	Published - 2001
Publication type	A1 Journal article-refereed

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

https://pubmed.ncbi.nlm.nih.gov/11583189

Cite this

Di, L. A., Gobert, PH., Closon-dejardin, MT., Dolci, S., Rouas, G., Paesmans, M., Lobelle, JP., Isola, J., Piccart, MJ., Larsimont, D., Gancberg, D., Järvinen, T., Beauduin, M., Vindevoghel, A., Michel, J., Focan, CH., & Ries, F. (2001). HER-2 and topo-isomerase IIalpha as predictive markers in a population of node-positive breast cancer patients randomly treated with adjuvant CMF or epirubicin plus cyclophosphamide. Annals of Oncology, 12(8), 1081-1089. https://pubmed.ncbi.nlm.nih.gov/11583189

@article{b4ac600d57b14f3e84456797041b000b,

title = "HER-2 and topo-isomerase IIalpha as predictive markers in a population of node-positive breast cancer patients randomly treated with adjuvant CMF or epirubicin plus cyclophosphamide",

author = "Di, \{Leo A\} and PH Gobert and MT Closon-dejardin and S Dolci and G Rouas and M Paesmans and JP Lobelle and J Isola and MJ Piccart and D Larsimont and D Gancberg and T J{\"a}rvinen and M Beauduin and A Vindevoghel and J Michel and CH Focan and F Ries",

year = "2001",

language = "English",

volume = "12",

pages = "1081--1089",

number = "8",

}

Di, LA, Gobert, PH, Closon-dejardin, MT, Dolci, S, Rouas, G, Paesmans, M, Lobelle, JP, Isola, J, Piccart, MJ, Larsimont, D, Gancberg, D, Järvinen, T, Beauduin, M, Vindevoghel, A, Michel, J, Focan, CH & Ries, F 2001, 'HER-2 and topo-isomerase IIalpha as predictive markers in a population of node-positive breast cancer patients randomly treated with adjuvant CMF or epirubicin plus cyclophosphamide', Annals of Oncology, vol. 12, no. 8, pp. 1081-1089. <https://pubmed.ncbi.nlm.nih.gov/11583189>

HER-2 and topo-isomerase IIalpha as predictive markers in a population of node-positive breast cancer patients randomly treated with adjuvant CMF or epirubicin plus cyclophosphamide. / Di, Leo A; Gobert, PH; Closon-dejardin, MT et al.
In: Annals of Oncology, Vol. 12, No. 8, 2001, p. 1081-1089.

Research output: Contribution to journal › Article › Scientific › peer-review

TY - JOUR

T1 - HER-2 and topo-isomerase IIalpha as predictive markers in a population of node-positive breast cancer patients randomly treated with adjuvant CMF or epirubicin plus cyclophosphamide

AU - Di, Leo A

AU - Gobert, PH

AU - Closon-dejardin, MT

AU - Dolci, S

AU - Rouas, G

AU - Paesmans, M

AU - Lobelle, JP

AU - Isola, J

AU - Piccart, MJ

AU - Larsimont, D

AU - Gancberg, D

AU - Järvinen, T

AU - Beauduin, M

AU - Vindevoghel, A

AU - Michel, J

AU - Focan, CH

AU - Ries, F

PY - 2001

Y1 - 2001

M3 - Article

SN - 1569-8041

VL - 12

SP - 1081

EP - 1089

JO - Annals of Oncology

JF - Annals of Oncology

IS - 8

ER -